Tranexamic Acid in Total Joint Arthroplasty
Publication Date: October 1, 2018
Last Updated: March 14, 2022
Recommendations
Administration of intravenous (IV), topical, and oral TXA as well as combinations of individual formulations of TXA are all effective strategies when compared to placebo for reducing calculated blood loss and the need for transfusion during the perioperative episode of a primary TJA. (S)
312070
Title
Tranexamic Acid in Total Joint Arthroplasty
Authoring Organization
American Association of Hip and Knee Surgeons